Soluble intercellular adhesion molecule (ICAM)-1 detects invasive fungal infections in patients following liver transplantation

References

• Angeletti, S., et al., 2013. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis s diagnosis. Clinical chemistry and laboratory medicine, 51 (5), 1059–1067.
   PubMed Web of Science ®Google Scholar
• Avni, T., Leibovici, L., and Paul, M., 2011. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. Journal of clinical microbiology, 49 (2), 665–670.
   PubMed Web of Science ®Google Scholar
• Barchiesi, F., et al., 2015. Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases. Liver transplantation, 21 (2), 204–212.
   PubMed Web of Science ®Google Scholar
• Borger, P., et al., 1999. Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. The journal of infectious diseases, 180 (4), 1267–1274.
   PubMed Web of Science ®Google Scholar
• Champagne, B., et al., 1998. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. Journal of immunology (baltimore, Md.: 1950), 161 (11), 6398–6405.
   PubMed Web of Science ®Google Scholar
• Clancy, C.J., and Nguyen, M.H., 2013. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clinical infectious diseases: an official publication of the infectious diseases society of america, 56 (9), 1284–1292.
   PubMed Web of Science ®Google Scholar
• Cornely, O.A., et al., ESCMID Fungal Infection Study Group. 2012. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical microbiology and infection : the official publication of the european society of clinical microbiology and infectious diseases, 18 (Suppl 7), 19–37.
   PubMed Web of Science ®Google Scholar
• De Pauw, B et al., European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical infectious diseases: an official publication of the infectious diseases society of america, 46 (12), 1813–1821.
   PubMed Web of Science ®Google Scholar
• Decker, S.O., et al., 2020. Soluble Intercellular Adhesion Molecule- (sICAM-) 1, Thrombospondin-1, and vinculin for the identification of septic shock patients suffering from an invasive fungal infection. Mediators of inflammation, 2020, 1–13.
   Web of Science ®Google Scholar
• Decker, S.O., et al., 2019. New approaches for the detection of invasive fungal diseases in patients following liver transplantation-results of an observational clinical pilot study. Langenbeck's archives of surgery, 404 (3), 309–325.
   PubMed Web of Science ®Google Scholar
• Decker, S.O., et al., 2017. Immune-response patterns and next generation sequencing diagnostics for the detection of mycoses in patients with septic shock-results of a combined clinical and experimental investigation. International journal of molecular sciences., 18, 1796.
   Web of Science ®Google Scholar
• Egusa, H., et al., 2005. Intercellular adhesion molecule 1-dependent activation of interleukin 8 expression in Candida albicans-infected human gingival epithelial cells. Infection and immunity, 73 (1), 622–626.
   PubMed Web of Science ®Google Scholar
• Eschenauer, G.A., et al., 2015. Targeted versus universal antifungal prophylaxis among liver transplant recipients. American journal of transplantation, 15 (1), 180–189.
   PubMed Web of Science ®Google Scholar
• Fortun, J., et al., 2003. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. Journal of antimicrobial chemotherapy., 52 (5), 813–819.
   PubMed Web of Science ®Google Scholar
• Fortun, J., et al.,; Grupo De Estudio De Infeccion En Pacientes Trasplantados-Grupo De Estudio De Micologia, M. & Red Espanola De Investigacion En Patologia, I. 2016. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis. Liver transplantation: official publication of the american association for the study of liver diseases and the international liver transplantation society, 22 (4), 427–435.
   PubMed Web of Science ®Google Scholar
• Giannella, M., et al., 2016. Antifungal prophylaxis in liver transplant recipients: one size does not fit all. Transplant infectious disease : an official journal of the transplantation society, 18 (4), 538–544.
   PubMed Web of Science ®Google Scholar
• Heidelberg University Hospital 2006. Heidelberger Manual der Lebertransplantation.
   Google Scholar
• Husain, S., et al., 2003. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation, 75 (12), 2023–2029.
   PubMed Web of Science ®Google Scholar
• Incamps, A., et al., 2018. Impact of biological matrix on inflammatory protein biomarker quantification based on targeted mass spectrometry. Bioanalysis, 10 (17), 1383–1399.
   PubMed Web of Science ®Google Scholar
• Kaltenborn, A., et al., 2015. Risk factors for short- and long-term mortality in liver transplant recipients with MELD score >/=30. Annals of transplantation, 20, 59–69.
   PubMed Web of Science ®Google Scholar
• Kidane, Y.H., Lawrence, C., and Murali, T.M., 2013. Computational approaches for discovery of common immunomodulators in fungal infections: towards broad-spectrum immunotherapeutic interventions. BMC microbiology, 13, 224.
   PubMed Web of Science ®Google Scholar
• Leeflang, M.M., et al., 2015. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane database syst rev, 2015, CD007394.
   Google Scholar
• Ley, K., et al., 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature reviews. Immunology, 7 (9), 678–689.
   PubMed Web of Science ®Google Scholar
• Ljungman, P., 2001. Prophylaxis against herpesvirus infections in transplant recipients. Drugs, 61 (2), 187–196.
   PubMed Web of Science ®Google Scholar
• Lyons, P.D., and Benveniste, E.N., 1998. Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia, 22 (2), 103–112.
   PubMed Web of Science ®Google Scholar
• Morris, P.J., 2004. Transplantation-a medical miracle of the 20th century. The New England journal of medicine, 351 (26), 2678–2680.
   PubMed Web of Science ®Google Scholar
• Mostefaoui, Y., et al., 2004. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cellular microbiology, 6 (11), 1085–1096.
   PubMed Web of Science ®Google Scholar
• Nagao, M., et al., 2016. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis. Journal of infection and chemotherapy : official journal of the Japan society of chemotherapy, 22 (2), 84–89.
   PubMed Web of Science ®Google Scholar
• Neofytos, D., et al., 2010. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transplant infectious disease, 12 (3), 220–229.
   PubMed Web of Science ®Google Scholar
• Patterson, T.F., et al., 2016. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clinical infectious diseases: an official publication of the infectious diseases society of america, 63 (4), e1–e60.
   PubMed Web of Science ®Google Scholar
• Pfeiffer, C.D., Fine, J.P., and Safdar, N., 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clinical infectious diseases : an official publication of the infectious diseases society of america, 42 (10), 1417–1427.
   PubMed Web of Science ®Google Scholar
• Reed, A., et al., 2007. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients. Liver transplantation : official publication of the american association for the study of liver diseases and the international liver transplantation society, 13 (12), 1743–1750.
   PubMed Web of Science ®Google Scholar
• Sayegh, M.H., and Carpenter, C.B., 2004. Transplantation 50 years later-progress, challenges, and promises. The new England journal of medicine, 351 (26), 2761–2766.
   PubMed Web of Science ®Google Scholar
• Sganga, G., et al., 2014. Fungal infections after liver transplantation: incidence and outcome. Transplantation proceedings, 46 (7), 2314–2318.
   PubMed Web of Science ®Google Scholar
• Shah, T., et al., 2005. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant infectious disease: an official journal of the transplantation society, 7 (3-4), 126–132.
   PubMed Web of Science ®Google Scholar
• Silveira, F.P., and Kusne, S, & Practice ASTIDCO. 2013. Candida infections in solid organ transplantation. American journal of transplantation : official journal of the american society of transplantation and the american society of transplant surgeons, 13 (Suppl 4), 220–227.
   PubMedGoogle Scholar
• Singh, N., 2003. Fungal infections in the recipients of solid organ transplantation. Infectious disease clinics of North America, 17 (1), 113–134. viii.
   PubMed Web of Science ®Google Scholar
• Singh, N., Singh, N.M., and Husain, S, & Practice ASTIDCO. 2013. Aspergillosis in solid organ transplantation. American journal of transplantation : official journal of the american society of transplantation and the american society of transplant surgeons, 13 (Suppl 4), 228–241.
   PubMedGoogle Scholar
• Singh, N., et al., 2015. Performance characteristics of galactomannan and beta-d-Glucan in High-risk liver transplant recipients. Transplantation, 99, 2543–2550.
   PubMed Web of Science ®Google Scholar
• Slifkin, M., Doron, S., and Snydman, D.R., 2004. Viral prophylaxis in organ transplant patients. Drugs, 64 (24), 2763–2792.
   PubMed Web of Science ®Google Scholar
• Trunecka, P., 2013. [Immunosuppression after liver transplant, now and in future]. Vnitr lek, 59, 671–677.
   PubMedGoogle Scholar
• Valenzuela-Sanchez, F., et al., 2016. New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure. Annals of translation medicine, 4, 329.
   PubMed Web of Science ®Google Scholar
• Vazquez, J.A., Miceli, M.H., and Alangaden, G., 2013. Invasive fungal infections in transplant recipients. Therapeutic advances in infectious disease, 1 (3), 85–105.
   PubMedGoogle Scholar
• Witkowska, A.M., and Borawska, M.H., 2004. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. European cytokine network, 15 (2), 91–98.
   PubMed Web of Science ®Google Scholar
• Xing, K., et al., 2012. Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Critical care (london, England)), 16 (1), R7.
   PubMed Web of Science ®Google Scholar
• Zonneveld, R., et al., 2014. Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults. Crit Care, 18 (2), 204.
   PubMed Web of Science ®Google Scholar